Several cancer patients, especially those with pancreatic or colorectal cancer, may develop diabetes or hyperglycemia [116,117]; GLP-1 RA can provide effective glycemic control with a low risk of hypoglycemia, which is crucial for maintaining energy levels and overall health during cancer treatment [118]. Here, GLP1R is linked to Hyperglycemia.